Illumina names Agilent executive as new CEO
JasonDoiy/iStock Unreleased via Getty Images

Illumina (NASDAQ:ILMN) announced Tuesday that its board of directors appointed Jacob Thaysen, president of Agilent Technologies' (A) Life Sciences and Applied Markets Group, as the company's new CEO, effective Sept. 25.
Since 2018, Mr. Thaysen has led Agilent's (A) Life Sciences and Applied Markets Group, which represents the Santa Clara, California-based company's largest segment and its analytical instrument portfolio and cell analysis franchise.

In 2022, the segment reported $4B in revenue and an operating margin of approximately 30% from over 50K customers.
With the appointment, Mr. Thaysen, 48, will relocate to the San Diego area from Northern California and will be part of Illumina's (ILMN) Board of Directors.
Charles Dadswell, who took over as interim CEO following the resignation of former CEO Francis de Souza in June, will resume his role as senior vice president and general counsel.



More on Illumina

Illumina added to Evercoreâs Tactical Outperform list on a potential CEO hire
Seeking Alphaâs Quant Rating on Illumina
Historical earnings data for Illumina
Financial information for Illumina
Illumina: Genetic Plot Twist, Time To Unravel The Stock

Illumina, Inc. (ILMN) UBS MedTech, Tools and Genomics Summit 2023 Conference (Transcript)
Illumina, Inc. 2023 Q2 - Results - Earnings Call Presentation

Illumina, Inc. (ILMN) Q2 2023 Earnings Call Transcript
Illumina under SEC investigation over GRAIL acquisition
Illumina cuts full-year guidance; shares fall 6% after hours